Professor | Yong He | Asia Growth Partners

Name

Yong He

Contact Information

heyong@simm.ac.cn

Language ability

Chinese, English

Province

Shanghai

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2013-09 to 2016-06 PhD: Anhui Medical University 2010-09 to 2013-06 Master's: Anhui Medical University
Work Experience	2019-07 to 2021-05 - National Institutes of Health, USA - Assistant Researcher 2016-07 to 2019-06 - National Institutes of Health, USA - Postdoctoral Researcher 2013-09 to 2016-06 - Anhui Medical University - PhD 2010-09 to 2013-06 - Anhui Medical University - Master's

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

Work Experience

2019-07 to 2021-05 - National Institutes of Health, USA - Assistant Researcher
2016-07 to 2019-06 - National Institutes of Health, USA - Postdoctoral Researcher
2013-09 to 2016-06 - Anhui Medical University - PhD
2010-09 to 2013-06 - Anhui Medical University - Master's

Areas of Focus	Anti-inflammatory and Immunopharmacology Hepatic Pharmacology
Publications	Oxidative stress promotes liver fibrosis by modulating the microRNA-144 and SIN3A-p38 pathways in hepatic stellate cells, Yong He, 2024 Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets, Yong He, 2023 MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression, Yong He, 2023 Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IjBf target genes in hepatocytes, Yong He, 2021 MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types, Yong He, 2021 Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis, Yong He, 2021 Immunopathobiology and therapeutic targets related to cytokines in liver diseases, Yong He, 2020 MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases, Yong He, 2020 MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes, Yong He, 2019 Hepatic Mitochondrial DNA/Toll-Like Receptor 9/MicroRNA-223 Forms a Negative Feedback Loop to Limit Neutrophil Overactivation and Acetaminophen Hepatotoxicity in Mice, Yong He, 2017

Areas of Focus

Anti-inflammatory and Immunopharmacology
Hepatic Pharmacology

Publications

Oxidative stress promotes liver fibrosis by modulating the microRNA-144 and SIN3A-p38 pathways in hepatic stellate cells, Yong He, 2024
Immune cells and their derived microRNA-enriched extracellular vesicles in nonalcoholic fatty liver diseases: Novel therapeutic targets, Yong He, 2023
MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression, Yong He, 2023
Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IjBf target genes in hepatocytes, Yong He, 2021
MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types, Yong He, 2021
Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis, Yong He, 2021
Immunopathobiology and therapeutic targets related to cytokines in liver diseases, Yong He, 2020
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases, Yong He, 2020
MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes, Yong He, 2019
Hepatic Mitochondrial DNA/Toll-Like Receptor 9/MicroRNA-223 Forms a Negative Feedback Loop to Limit Neutrophil Overactivation and Acetaminophen Hepatotoxicity in Mice, Yong He, 2017

Inflammation Immunity Pharmacology Liver Disease Therapy Microrna Fibrosis Hepatitis Cells

Wanzhu Jin - University of Chinese Academy of Sciences

Yong Zhou - University of Chinese Academy of Sciences

Zhuo Wang - Southern University of Science and Technology

View All

Personal Information